Chair, Dept of Radiation Medicine and Co-Exec Director, North Shore-LIJ Cancer Institute
Radiation Oncology
Dr. Louis Potters, MD
|
|
Give Review
Louis Potters, MD is an expert in the field of Radiation Oncology. He studied medicine at Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76/0 in Research/PrimaryCare. He received 8 awards: "America's Top Doctors", "Top Doctors: New York Metro Area", "Newsday - Top Doctors on Long Island", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "New York Magazine: Top Doctors", "Best doctor" and "Top MD". Louis Potters is also a published doctor. He has 86 publication published. The most recent publication is: Effects of pretreatment transurethral resection on survival in prostatic carcinoma. Louis Potters, MD accepts all Medicare patients.
Publications
- Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
- A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
- Prospective contouring rounds: A novel, high-impact tool for optimizing quality assurance.
- The dangers of incorporating reimbursement data into clinical decision making.
- Establishing high-quality prostate brachytherapy using a phantom simulator training program.
- Physician attitudes and practices related to voluntary error and near-miss reporting.
- American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).
- Practice-Based Evidence to Evidence-Based Practice: Building the National Radiation Oncology Registry.
- In reply to baer.
- The paradox of multidisciplinary care.
- Choosing Wisely: The American Society for Radiation Oncology's Top 5 list.
- The safety hazard.
- American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing practice impro...
- Incident Learning and Failure-Mode-and-Effects-Analysis Guided Safety Initiatives in Radiation Medicine.
- Development, implementation, and compliance of treatment pathways in radiation medicine.
- Long-term outcomes in younger men following permanent prostate brachytherapy.
- Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated...
- 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.
- Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer.
- Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.
- The art of radiation oncology?
- Stereotactic body radiation therapy.
- Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United St...
- Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
- Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
- Comparison of biochemical failure definitions for permanent prostate brachytherapy.
- A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systems.
- Permanent prostate brachytherapy: a century of technical evolution.
- Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
- Permanent prostate brachytherapy: Dosimetric results and analysis of a learning curve with a dynamic dose-feedback technique.
- Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
- Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
- American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy.
- The role of external radiotherapy in patients treated with permanent prostate brachytherapy.
- Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
- External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer.
- The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
- Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
- Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiothe...
- Importance of implant dosimetry for patients undergoing prostate brachytherapy.
- Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques.
- Permanent prostate brachytherapy in men with clinically localised prostate cancer.
- A chronological database to support outcomes research in prostate cancer.
- The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.
- How one defines intensity-modulated radiation therapy.
- A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
- Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair a...
- Nomograms for clinically localized prostate cancer. Part II: radiation therapy.
- Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.
- Potency after permanent prostate brachytherapy for localized prostate cancer.
- A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.
- A theoretical derivation of the nomograms for permanent prostate brachytherapy.
- The definition of biochemical failure in patients treated with definitive radiotherapy.
- Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
- Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
- Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
- Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
- Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
- Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
- Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
- Permanent prostate brachytherapy: lessons learned, lessons to learn.
- Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer.
- Iodine-125 vs. palladium-103: long-term complications.
- A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
- Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy.
- Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
- Isotope selection for patients undergoing prostate brachytherapy.
- Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.
- Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
- Effects of pretreatment transurethral resection on survival in prostatic carcinoma.
- Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma.
- Diminished survival of young blacks with adenocarcinoma of the prostate.
- Locally advanced paranasal sinus and nasopharynx tumors treated with hyperfractionated radiation and concomitant infusion cisplatin.
- Comprehensive management including interstitial brachytherapy for locally advanced or recurrent gynecologic malignancies.
- American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
- Perspective on...the new PSA screening recommendations.
- American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate ca...
- Apples to apples.
- Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.
- The second decade of prostate brachytherapy: evidence and cost based outcomes.
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body rad...
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT).
- Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth.
- Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic vari...
- Radiation therapy approaches to the treatment of high-risk prostate cancer.
Schools
UMDNJ New Jersey Medical School
Beth Israel Mc
Suny Dwnst
Doctors Specialties
- Internal Medicine
- Radiation Oncology
Accepted Insurances
- Amerigroup (Wellpoint)
- Blue Card PPO
- Capital District Physician's Health Plan (CDPHP) HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Emblem Health
- GHI PPO
- Health Insurance Plan of Greater New York (HIP) PPO
- Empire Blue Cross Blue Shield HMO
- Pathway Enhanced Guided Access
- Fidelis Care HMO
- ABCD HMO
- Locals (any local)
- MagnaCare PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Neighborhood Health Plan
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- America's Top Doctors
- Top Doctors: New York Metro Area
- Newsday - Top Doctors on Long Island
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- New York Magazine: Top Doctors
- Best doctor
- Top MD
Education
-
SUNY Health Science Center at Brooklyn -
Mount Sinai Beth Israel -
Rutgers New Jersey Medical School
Hospital
-
Glen Cove Hospital -
Lenox Hill Hospital -
Long Island Jewish Medical Center -
North Shore University Hospital -
Southside Hospital
Drug Facts
| NPI NUMBER | 1083614184 | |
| NPPES Provider LastName | POTTERS | |
| NPPES Provider FirstName | LOUIS | |
| NPPES Provider ZIPCode | 115721548 | |
| NPPES Provider State | NY | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 51.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083614184 |
| Last Name Of The Provider | POTTERS |
| First Name Of The Provider | LOUIS |
| View All |
Similar Doctors
|
|
Dr. Evelyn S. Marienberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Janna Z. Andrews, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samta Jain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dipti Ravindranath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doron Israelski, MD
This Doctor is OpenDoctor Recommended.
|